Jose Juan Quesada
Compatibilidad fármacos IV
Publisher DNA
What defines Jose Juan Quesada?
AI intelligence is not yet available for Jose Juan Quesada. The portfolio data below is up to date.
Portfolio
What does Jose Juan Quesada ship?
Apps
2 apps analysed
Which IV drugs can be administered, or not, simultaneously according to the literature?
Analysis in progress
Single-market publisher, every app ships only to United States.
Based on 1 of 2 apps with localized market data, more coverage rolling in as scans complete · last scanned .
Americas (1)
- United States1 / 1
Core markets (1/1 apps)
Rivals
Who does Jose Juan Quesada compete with?
The rivals identified
Nemeses(1)
Both apps target hospital-based clinicians needing medication safety data, creating a direct conflict for the same professional's limited mobile screen time.
Contenders(8)
Both apps target healthcare professionals requiring medication data, though the rival serves a broader consumer audience while the target app focuses on clinical intravenous compatibility.
Both apps target healthcare professionals requiring clinical drug information, with epocrates providing a broader decision support platform that overlaps with the specific intravenous compatibility focus of the target app.
Both apps target healthcare professionals requiring clinical reference data, creating direct competition for the same professional user base.
Both applications target healthcare professionals managing intravenous medications, creating direct competition for clinical reference utility in hospital and emergency settings.
MediHelp competes for the same hospital-based healthcare professional audience by offering a broader clinical reference suite that includes IV guidance alongside general drug information. The overlap in professional utility forces a direct choice between specialized IV stability data and a multi-functional clinical tool.
Both applications target hospital-based clinicians requiring specialized pharmacological reference data to support patient safety during clinical decision-making. They compete for the same professional attention during medication administration workflows.
Provides nursing-focused drug monographs and dosing tools that overlap with the clinical reference needs of the target audience.
Both apps target hospital pharmacy professionals in Spain, creating a shared audience overlap where clinicians seek professional resources. While Compatibilidad fármacos IV focuses on clinical decision support, APP SEFH serves as the official communication portal for the Spanish Society of Hospital Pharmacy.
Same space(7)
Provides evidence-based infectious disease treatment guidelines and drug interaction tools for the same clinical audience.
Targets individuals managing personal medication regimens, providing a broader utility than the clinical-focused source app.
Provides a reporting mechanism for adverse drug reactions, serving as a safety-focused utility for healthcare professionals and patients.
Focuses on medication safety and interaction tracking, though it targets a consumer audience rather than hospital clinicians.
Assists clinicians in emergency settings with protocols and dosing calculators, sharing the clinical decision-support focus of the source app.
Acts as a general-purpose drug reference for nurses, providing information on dosages and interactions.
Targets nursing professionals with integrated IV calculators and drug monographs for clinical safety.
